Pandit-Taskar N, O'Donoghue JA, Chetty D, Max S, et al. A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer. J Nucl Med 2024 May 23:jnumed.124.267416. doi: 10.2967/jnumed.124.267416.
PMID: 38782459